Table 2.
ICD-10 | Cancer site | No. of cases |
SIR | 95% CI |
---|---|---|---|---|
C00–C97 | All sites | 232 | 1.06 | 0.93–1.20 |
C00–C97, except C44 | All sites, except other skin | 219 | 1.08 | 0.94–1.23 |
C00–C14 | Mouth, pharynx | 24 | 1.70 | 1.09–2.52 |
C07–C08 | Salivary glands | 0 | 0.00 | 0.00–4.57 |
C09–C14 | Pharynx | 16 | 2.41 | 1.38–3.91 |
C15–C26 | Digestive organs | 62 | 1.11 | 0.85–1.42 |
C15 | Oesophagus | 12 | 2.38 | 1.23–4.15 |
C16 | Stomach | 19 | 0.93 | 0.56–1.45 |
C18 | Colon | 12 | 1.18 | 0.61–2.06 |
C19–C21 | Rectum | 9 | 1.17 | 0.54–2.23 |
C22 | Liver | 2 | 0.78 | 0.09–2.82 |
C30–C39 | Respiratory organs | 51 | 1.02 | 0.76–1.34 |
C32 | Larynx | 7 | 0.91 | 0.37–1.88 |
C33–C34 | Trachea, bronchus, lung | 42 | 1.02 | 0.74–1.38 |
C40–C41 | Bone | 2 | 2.08 | 0.25–7.50 |
C43 | Melanoma of skin | 6 | 1.14 | 0.42–2.49 |
C44 | Other skin | 13 | 0.82 | 0.43–1.39 |
C45–C49 | Mesothelial and soft tissues | 1 | 0.44 | 0.01–2.42 |
C50 | Breast | 0 | 0.00 | 0.00–13.54 |
C60–C63 | Male genital organs | 16 | 0.70 | 0.40–1.14 |
C61 | Prostate | 13 | 0.89 | 0.48–1.53 |
C64–C68 | Urinary organs | 18 | 0.84 | 0.50–1.33 |
C69 | Eye | 0 | 0.00 | 0.00–9.19 |
C70–C72 | Central nervous system | 12 | 1.91 | 0.99–3.34 |
C71 | Brain | 10 | 1.71 | 0.82–3.15 |
C73 | Thyroid gland | 2 | 1.41 | 0.17–5.10 |
C74–C75 | Other endocrine | 0 | 0.00 | 0.00–17.32 |
C76–C80 | Site unknown or uncertain | 7 | 1.27 | 0.51–2.62 |
C81 | Hodgkin lymphoma | 3 | 1.39 | 0.29–4.06 |
C82–C85, C96 | Non-Hodgkin lymphoma | 6 | 1.16 | 0.43–2.53 |
C88, C90 | Multiple myeloma, immunoproliferative diseases |
2 | 1.00 | 0.12–3.60 |
C91–C95 | Leukaemia | 7 | 1.22 | 0.49–2.51 |
C07–C08, C15, C16,
C18, C33–C34, C40–C41, C44, C64–C68, C70–C73, C91–C95 (except C91.1) |
Radiation-related sites | 135 | 1.06 | 0.88–1.24 |
C01–C15, C18–C22, C32 | Alcohol-related sites | 66 | 1.42 | 1.09–1.80 |